IMMUNOGLOBULIN G1 (233-PROLINE,234-ALANINE,235-ALANINE,DE-237-GLYCINE,329-ALANINE), ANTI-(HUMAN PROGRAMMED CELL DEATH LIGAND 1) (HUMAN-MUS MUSCULUS MONOCLONAL BGB-A333 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BGB-A333 .KAPPA.-CHAIN, DIMER
Advanced Solid Tumors
BeiGenemonoclonal_antibodyPhase 1/2Dormant
CC
40/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 59/ 100
Competitive context
1412 Active assets in the Advanced Solid Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Nabiximols Jazz Pharmaceuticals | Phase 3 | BBB |
Inno-206 M.D. Anderson Cancer Center | Phase 2 | BB |
Vitamin B6 M.D. Anderson Cancer Center | Phase 4 | BB |
PROPOFOL Hong Kong Children's Hospital | Phase 4 | BB |
Rivoceranib Jiangsu HengRui Medicine Co., Ltd. | Phase 4 | BB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →